Table 1 Twenty-eight studies of breast texture features classified from mammograms included in systematic review (sorted by year published)
References | Year | City/institution | Study design | Machine type | View used (CC/MLO/both) | # cases | # controls |
|---|---|---|---|---|---|---|---|
Choi et al. [28] | 2016 | University of Ulsan | Retrospective cohort | General Electric Senographe DS and film | Both | 240 | 0 |
Malkov et al. [38] | 2016 | USA | Case–control studies with 2 of 5 nested in cohorts | Film | CC | 1171 | 1659 |
Tan et al. [43] | 2016 | University of Pittsburgh Medical Center | Case–control | Digital (not specified further) | Both | 159 | 176 |
Winkel et al. [49] | 2016 | Bispebjerg Hospital | Prospective cohort with case–control sampling | Film | Both | 121 | 259 |
Ali et al. [26] | 2017 | Sweden | Main analysis: case–control. Validation study: prospective cohort | Film for main analysis, GE Senographe Essential for validation study | MLO | 1170 for main analysis, 69 for validation study | 1283 for main analysis, 231 for validation study |
Eriksson et al. [29] | 2017 | Sweden | Prospective cohort with case–control sampling | Digital (not specified further) | Both | 433 for model development. An additional 137 women lacking information were included in calculating the absolute risk estimates | 1732 when comparing study participant characteristics and mammographic features, 60,237 for calculating the absolute risk estimate |
Wang et al. [45] | 2017 | National Health Service | Prospective cohort with case–control sampling | GE Senographe system | CC | 264 for training case–control study, 317 for validation case–control study | 787 for training, 931 for validation |
Winkel et al. [48] | 2017 | Copenhagen, Denmark | Prospective cohort of false positives with case–control sampling | Film | Both | 288 | 288 |
Yan et al. [50] | 2017 (August) | NR | Case–control | Hologic Selenia | CC | 83 | 85 |
Yan et al. [51] | 2017 (October) | NR | Case–control | Hologic Selenia | CC | 83 | 85 |
Gastounioti et al. [31] | 2018 | University of Pennsylvania | Case–control | Hologic Selenia Dimensions | MLO | 115 | 460 |
Heidari et al. [32] | 2018 | NR | Case–control | Digital (not specified further) | CC | 250 | 250 |
Li et al. [37] | 2018 | Fudan University Shanghai Cancer Center | Nested case–control prospective cohort | NR | CC | 84 | 987 |
Schmidt et al. [40] | 2018 | Australia and Hawaii, USA | Case–control and nested case–control in prospective cohort | Film | CC | 1236 | 2931 |
Tagliafico et al. [42]* | 2018 | Italy | Case–control | Hologic Selenia Dimensions | NR | 20 | 20 |
Ward et al. [46] | 2018 | National Health Service | Prospective cohort | Hologic Selenia | Both | 34 | 746 |
Evans et al. [30] | 2019 | Bradford (UK) Teaching Hospitals NHS Foundation Trust | Case–control | Digital (not specified further) | Mix of CC and MLO | 58 images from 35 patients with cancer. Experiment 1D included an additional 50 abnormal mammograms with visible cancerous lesions taken from 50 patients | 58 images from 35 patients without cancer. Experiment 1D included an additional 50 normal mammograms taken from 50 patients |
Hsu et al. [34] | 2019 | University of California, Los Angeles | Prospective cohort | NR | NR | 463 biopsy results | 1675 biopsy results |
Kontos et al. [35] | 2019 | University of Pennsylvania for case–control sample for evaluating associations to breast cancer, NR for screening sample for phenotype identification | Sample used in evaluating associations to breast cancer: case–control. Sample used for phenotype identification: cross-sectional | Hologic Selenia Dimensions for screening sample, GE Senographe 2000D and DS for case–control sample | Both for screening sample, NR for case–control sample | Screening sample included 18 detected cases with 12 in the training sample and 6 in the testing sample. 76 cases were in case–control sample | Screening sample included 2011 controls with 1327 in the training sample and 684 in the testing sample. 158 controls were in case–control sample |
Perez-Benito [39] | 2019 | Valencian Community, Spain | Case–control from population screening program | FUJIFILM, IMS s.r.l., Giotto IRE, HOLOGIC, SIEMENS, or unknown | Both | 808 cases with 606 in training set and 202 in test set | 755 with 566 in training set and 189 in test set |
2019 | Tampere University Hospital | Case–control | Philips MicroDose SI or General Electric Senographe Essential | CC | 114 | 114 | |
Tan et al. [44] | 2019 | Subang Jaya Medical Center | Case–control | Hologic Selenia | CC | 250 | 250 |
Abdolell et al. [25] | 2020 | NR | Case–control from population screening program | Siemens MAMMOMAT Inspiration or MAMMOMAT Novation DRimaging system | Both | 1882 | 5888 |
Ma et al. [36] | 2020 | Nanfang Hospital | Case–control | Hologic Selenia Dimensions | Both | 608 for risk model development, 203 for validation | 1261 for risk model development, 421 for validation |
Sorin et al. [41] | 2020 | NR | Retrospective cohort | GE Senographe Essential | Both | 53 | 463 |
Azam et al. [27] | 2021 | Sweden | Prospective cohort | General Electric, Philips, Spectrum Hologic, and Siemens | Both | 676 | 52,597 |
Heine et al. [33] | 2021 | Mayo Clinic for first case–control study, the San Francisco Mammography Registry for generalization study | Case–control | Hologic Selenia | CC | 514 for first study, 1474 for generalization study | 1377 for first study, 2942 for generalization study |
Warner et al. [47] | 2021 | USA | Prospective cohort with case–control sampling | Film | CC | 1900 | 3921 |